1. Home
  2. TOWN vs PTGX Comparison

TOWN vs PTGX Comparison

Compare TOWN & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TowneBank

TOWN

TowneBank

HOLD

Current Price

$34.14

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$97.38

Market Cap

6.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOWN
PTGX
Founded
1998
2006
Country
United States
United States
Employees
2976
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
6.4B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
TOWN
PTGX
Price
$34.14
$97.38
Analyst Decision
Strong Buy
Analyst Count
0
13
Target Price
N/A
$108.23
AVG Volume (30 Days)
494.4K
462.9K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
3.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.05
Revenue
N/A
N/A
Revenue This Year
$35.63
$874.25
Revenue Next Year
$5.18
N/A
P/E Ratio
$16.23
$2,055.80
Revenue Growth
N/A
N/A
52 Week Low
$31.91
$49.86
52 Week High
$37.86
$107.84

Technical Indicators

Market Signals
Indicator
TOWN
PTGX
Relative Strength Index (RSI) 49.45 47.17
Support Level $32.03 $96.36
Resistance Level $35.01 $104.85
Average True Range (ATR) 0.63 4.25
MACD -0.02 -0.26
Stochastic Oscillator 59.42 42.59

Price Performance

Historical Comparison
TOWN
PTGX

About TOWN TowneBank

Towne Bank is a financial services company serving individuals, commercial enterprises and professionals, offering retail and commercial banking services in Virginia and North Carolina. The company has four reportable segments: Banking, which provides loan and deposit services, commercial mortgage brokerage, and investment and asset management services; Mortgage, which originates mortgage loans principally sold in the secondary market through purchase commitments from investors; Resort Vacation Management, which provides residential resort property management services; and Insurance, which provides property, casualty, life and health insurance solutions for businesses, individuals and community organizations through a variety of carriers.

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

Share on Social Networks: